En Es
Categories

Industry News


Transasia Showcases Clinical Lab Solutions at APPI 2017

By Labmedica International staff writers
16 Jun 2017

Image: The Sysmex XN-330 hematology analyzer, one of three analyzers showcased at the APPI 2017 conference (Photo courtesy of Transasia).Transasia Bio-Medicals Ltd. (Mumbai, India), an in-vitro diagnostic company, will be the technology partner as well as principal partner of the 4th Annual Conference hosted by the Association of Practicing Pathologists of India (APPI-Mumbai), held June 16-18, 2017, in Mumbai, India.

Transasia, a part of the global Erba Diagnostics Mannheim GmbH Group, offers solutions and products in biochemistry, hematology, coagulation, ESR, immunology, urinalysis, critical care, diabetes management, microbiology and molecular diagnostics. During the three-day event, which will be attended by over 1,000 practicing pathologists from India and across the world, the company will introduce new products and processes that provide an end-to-end solution for improved lab efficiency. Transasia will be introducing Sysmex XN-330, the latest six-part differential hematology analyzer as well as showcasing the EM 200, a fully automated biochemistry analyzer, and the ECL 760 coagulation analyzer.

Additionally, Transasia will also organize interactive scientific sessions and workshops led by experienced industry veterans in the fields of hematology, biochemistry and coagulation. This will provide an important forum for practicing pathologists and lab owners to engage in a dialogue about critical compliance and operational challenges, as well as open the doors for further discussions on the best practice approaches for addressing those challenges.



E-mail Print
FaceBook Twitter Google+ Linked in

ERBA MANNHEIM

Erba Diagnostics Mannheim, a company registered in Mannheim, Germany supplies Instruments, Reagents and Consumables conforming to IVD Directives.  It is a ISO 13485 : 2003 certified company. The requisite expertise and technical edge have made Erba “The Company of Choice” for supplying instruments under OEM labels for many diagnostic companies across Europe and Asia.
Gold member
More info

Additional news

12 Dec 2017
TeraRecon to Sell EnvoyAI Platform
TeraRecon, a provider of advanced visualization solutions, has entered into a distribution partnership with EnvoyAI to sell and market the EnvoyAI platform. The platform includes a content-rich artificial intelligence (AI) marketplace, called the EnvoyAI Exchange, as well as a suite of market-ready AI-enablement technologies aimed at fostering broader access and clinical use of medical imaging algorithms within busy radiology practices.
Read More
12 Dec 2017
Google Releases AI Tool for Precision Medicine
Google LLC has announced the open source release of DeepVariant, a deep learning technology to reconstruct the true genome sequence from high-throughput sequencing (HTS) data with significantly greater accuracy than previous classical methods. DeepVariant, which was developed after more than two years of research by the Google Brain team, in collaboration with Verily Life Sciences, transforms the task of variant calling, as this reconstruction problem is known in genomics, into an image classification problem well-suited to Google's existing technology and expertise. Within a year of its development, the deep learning model had won the 2016 PrecisionFDA Truth Challenge award for Highest SNP Performance, outperforming state-of-the-art methods. Since then, the Google Brain team has reduced the error rate by over 50%.
Read More
11 Dec 2017
Esaote to Be Acquired by Consortium of Chinese Healthcare Companies
Esaote S.p.A. has entered into definitive agreements with a consortium of Chinese investors who will acquire the entire share capital of the company. The consortium acquiring Esaote comprises leading medical technology and healthcare companies, as well as financial investors with significant experience in the healthcare sector.
Read More
06 Dec 2017
Global Hybrid OR Market to Reach USD 1,17 Million by 2022
The global hybrid operating room (OR) market is expected to grow at a CAGR of 12.5% from USD 652.0 million in 2017 to USD 1,174.9 million by 2022, driven by technological advancements in robot-assisted surgeries, increasing minimally invasive surgeries, and growing patient preference for affordable & effective surgical treatments. However, high establishment costs and procedural risks for patients associated with hybrid ORs are expected to limit the market growth during 2017 to 2022.
Read More
06 Dec 2017
Siemens to List Siemens Healthineers on Frankfurt Stock Exchange
Siemens AG, a provider of medical imaging and laboratory diagnostics equipment, is preparing to list its separately managed healthcare unit, Siemens Healthineers, on the Prime Standard segment of the Frankfurt Stock Exchange's Regulated Market. The move was approved at a meeting by the company's Supervisory Board and has been planned for the first half of 2018. Siemens Healthineers AG will be established for the public listing.
Read More
06 Dec 2017
GE Healthcare and Nuance Partner with NVIDIA to Bring AI to Medical Imaging
Healthcare-solution providers GE Healthcare and Nuance Communications, Inc., have partnered with NVIDIA, a leader in visual computing technologies, for using the company’s deep learning platform to bring Artificial Intelligence (AI) to medical imaging.
Read More
06 Dec 2017
Neuroimaging Platform Uses 3D AI to Offer Brain Visualization
QMENTA, a medical image storage, processing and visualization company focused on brain data analysis, specifically using MRI and related clinical data, has developed a cloud-based system for neuroimages and all related data, with data management, analysis and visualization capabilities.
Read More
05 Dec 2017
GE Launches Drawbridge Health to Transform Blood Collection
GE Healthcare has introduced Drawbridge Health, a privately held healthcare technology company, which is developing a people-friendly system to integrate draw, collection and stabilize blood samples into a single device. The technology which integrates engineering and proprietary chemistries is also being developed to support room temperature shipping and streamlined downstream processing, thus ensuring reliable, accurate results.
Read More
29 Nov 2017
CE Mark Awarded to First Commercial Head And Neck Deep Learning Solution
The world's first commercial head and neck deep learning medical imaging solution from Aidoc, an AI startup utilizing deep learning to augment radiologists' workflow and highlight anomalous cases, has received CE (Conformité Européenne) marking, allowing for its widespread commercialization in Europe.
Read More
Copyright © 2000-2017 TradeMed.com. All rights reserved. | Terms And Conditions